Thorium dioxide was first used for radiographic imaging studies as early as 1915. Carcinogenesis was clearly established by the 1940s, such that by 1956 worldwide usage had ceased. Malignancies were noted to appear from 15 to 45 years after injection. A case of thorotrast-induced hepatic angiosarcoma is presented, which was complicated by disseminated intravascular coagulation and microangiopathic hemolytic anemia. Since multiple medical conditions existed, it was unclear which was primarily responsible for these complications. This is the first reported association between thorotrast-induced malignancy and disseminated intravascular coagulation. The world literature is reviewed.
Rudolphi H.Spatentwicklung eines Unterlidkarzinoms nach Thonumoxydinjektion. Beitr Pathol Anat1950;111: 158-64.
2.
Wustrow PU, Behbehani A., Wiebecke B.Thorotrast-induced oropharyngeal and hypopharyngeal fibrosis with recurrent bleeding. Cranio-Max-FacSurg1988 ;16:315-9.
3.
Bluhbaum T., Frik K., Kalkbrenner H.Eine neue Anwendungsart der Kolloide in der Rongendiagnostik. ROFO1928; 37:18-29.
4.
Goren AD, Harley N., Eiseribud L., Levin S., Cohen N.Clinical and radiobiological features of thorotrast-induced carcinoma of the maxillary sinus: a case report. Oral Surg1980;49:237-42.
5.
American Medical Association.Editorial: Council on Pharmacy and Chemistry: thorotrast. JAMA1932;99:2183-5.
6.
Oberling CH, Guerin M.Action du thorotrast sur le sarcome de Jensen du rat blanc. Bull Assoc FranceCancer1933;22:469-89.
7.
Roussy G., Oberling CH, Guerin M.Action canceigene du dioxyde de thorium chez le rat blanc. Bull Acad Natl MedParis1934 ; 112:809-1,9.
8.
MacMahon HE, Murphy A., Bates M.Sarcoma of the liver: disadvantages of thorotrast as a diagnostic agent, RevGastroenterol1947;14:155-9.
9.
Linder EACarotid-artery rupture as a late effect of thorotrast angiography . Oto-Rhino-Laryngol1981;43:309-13.
10.
Mori T., Maruyama T., Kato Y., Takahashi S.Epidemiological follow-up study of Japanese thorotrast cases. Environmental Res1979a;18:44-54.
11.
Blumel G., Lehner R., Zaunbauer W.Zum Thorotrast-Problem. Wien Med Wochenschr1964;20:345-8.
12.
Autenrieth J., Lange S.Thorotrastosen: Ein Ruckblick. Rontgenblatter1979;32.-71-4.
13.
Kamiyama R. , Ishikawa Y., Hatakeyama S., Mori T., Sugiyama H.Clinicopathological study of hematological disorders after Thorotrast administration in Japan . Blut1988;56: 153-60.
Verhaege M. , Adenis L., Demaille A., Tomeau M.Thorotrastome parotidin: a propos d'une observation anatomoclinique. J Chir (Paris) 1970;100:271.
16.
Gaus H., Gulzow M., Meyer-Hofmann G.Spatschaden nach Thorotrastanwendung. Klin Wochenschr1966;44:32-9.
17.
Heger N., Bayindir S.Thorotrast: primary liver sarcoma 22 years after administration. Minn Med1970;53:1137-9.
18.
Da Silva Horta J., Abatt L., da Motta L.Malignancy and other late effects following administration of Thorotrast. Lancet1965;2:201-5.
19.
Basorga R., Yokoo H., Heneger G.Thorotrast-induced cancer in man. Cancer1960 ;13:1021-31.
20.
Kato I., Kido C.Increased risk of death in thorotrast-exposed patients during late follow-up period. Jpn J Cancer Res1987;78:1187-92.
21.
Kiyosawa K. Imai H., Sodeyama T., et al. Comparison of anamnestic history, alcohol intake and smoking, nutritional status and liver dysfunction between thorotrast patients who developed primary liver cancer and those who did not . Environmental Res1989;49:166-72.
22.
Mori T., Kato Y., Shimamine T., Watanabe S.Statistical analysis of Japanese thorotrast-administered autopsy cases . Environmental Res1979b;18:231-44.
23.
Looney WBInvestigation of the late clinical findings following thorotrast (thorium dioxide) administration. Am J Roentgenol1960 ;83:163-85.
24.
Ito Y., Kojiro M., Nakashima T., Mori T.Pathomorphological characteristics of 102 cases of thorotrast-related hepatocellular carcinoma, cholangiocarcinoma, and hepatic angiosarcoma. Cancer. 1988;62:1153-62.
25.
Van Kaick G. , Lieberman D., Lorenz D., et al. Recent results of the German thorotrast study: Epidemiological results and dose effect relationships in thorotrast patients. Health Phys1983;44:299-306.
26.
Gobets MA, Nowotny H., Ruzicka F., Hanak H., Stacher A.A case of acute lymphoblastic leukemia and thorotrast accumulation . Blut1975;31:5-10.
27.
Thierbach R. , Bothe H., Langer H.Spatschaden nach Thorotrast-injektion mit besonderer Berucksichtigung physikalisch-quantitativer Befunde. Fortschr Rontgenstr1960;93:298-313.
28.
Van Kaick G , Lorenz D., Muth H., Kaul A.Malignancies in German thorotrast patients and estimated tissue dose. Health Phys1978 ;35:127-36.
29.
Bauer KHThorotrast and Krebsgefahr. Chirurgie1943 ;15: 204-7.
30.
Stanley RB, Calcaterra T.Management of cervical thorium dioxide granulomas. Arch Otolaryngol1981;107:631-4.
31.
Abbatt JDHistory of the use and toxicity of thorotrast. Environmental Res1979;18:6-12.
32.
Arlt B., Bohm E., Jung HG, Beyer H.Nierenkarzinom nach retrograder Pyelographie mit Thorotrast vor 45 Jahren . Med Welt1977;28:1725-7.
33.
Sasaki F., Kido C., Sato Y., Tatano H.Roentgenologic appearance of thorotrast-induced small cholangiocarcinoma in a case of thorotrastosis: an autopsy case of massive gastrointestinal bleeding of esophageal varices. Nippon Igaku HoshasonGakkai Zasshi1989;49:568-73.
34.
Odemar F., Richter K., Jager H., Grafenstein K.Thorotrastosis: a rare disease picture in internal medicine. Z Gasamte Inn Med1989;44:589-91.
35.
Backer OG, Faber M., Rasmussen H.Local sequelae to carotid angiography with colloid thorium dioxide . Acta Chir Scand1958;115:417-21.
36.
Kamijo A., Okabe K., Hirose T.Thorium dioxide granuloma of the neck with resultant fatal hemorrhage . Arch Otolaryngol1979;105:45-7.
37.
Kojiro M., Nakashima T., Ito Y., Itezaki H.Pathomorphological study on thorotrast-induced hepatic malignancy . In: Gossner W, Gerber G, Hagen U, Luz A, eds. The radiobiology of radium and thorotrast. Munich: Urban and Schwarzenberg , 1986:119-22.
38.
Kamada N.Cytogenic studies in patients with myelodysplastic syndrome. Jpn J Clin Hematol1986;27:1765-72.
39.
Johnson SA, Bateman C., Beard M., Whitehouse J., Waters A.Long-term haematologic complications of thorotrast. Q J Med New Ser1977;46:259-71.
40.
Mole RHLeukaemia induction in man by radionuclides and some relevant experimental and human observations. In: Gossener W, Gerber G, Hagen U, Lutz A, eds. The radiobiology of radium and thorotrast. Munich: Urban and Schwarzenberg , 1986:1-13.
41.
Mori T., Kato Y., Aoki N., Hatakeyama S.Statistical analysis of Japanese thorotrast-administered autopsy cases— 1980. Health Phys1983;44:281-92.
42.
Mori T., Kato Y., Ishara T., et al. The effects of thorium on the human being. In: Shibata T, Kanda K, Kobayashi K, eds. Research on, thorium fuel, SPEY 9, Report of the Ministry of Education, Science and Culture of Japan, 1984:229-50.
43.
Sadamori N. , Shima M., Yano M., et al. An autopsy case of dysmyelopoietic syndrome with marked chromosomal abnormalities induced by thorotrast. Jpn J Clin Hematol1985;26:1641-6.
44.
Shimahine T. , Mori T.Bone marrow findings in thorotrast-administered cases. In: Hibino S, ed. Research on aplastic anemia , vol. 5. Report of the Ministry of Health and Welfare of Japan, 1976:123-9.
45.
Bastrup-Madsen P., Nielsen K., Mose C.Acute erythraemia (Di Guglielmo's syndrome) after thorotrast injection. Acta Med Scand1971;189:349-53.
46.
Parreira F. , DeMoura M.Morphological study of the bone marrow in patients injected with Th02. Environmental Res1979;18:61-4.
47.
Faber M.Twenty-eight years of continuous follow-up of patients injected with thorotrast for cerebral angiography. Environmental Res1979;18:37-43.
48.
Tavares M., Saragoca A., Oliveira E., Rocha Oliveira M, Da Silva Horta J. Thorium dioxide and the liver: up-dated clinical and biochemical findings, Environmental Res1979;18: 173-7.
49.
Da Silva Horta J., Abbatt J., Cayolla da Motta L., Tavares M.Leukaemia, malignancies and other late effects following administration of thorotrast. Z Krebsforsch1972;77:202-16.
50.
Mihatsch M. , Rutishauser G.Thorotrast induced transitional cell carcinoma in a residual ureter after nephrectomy. Cancer1973;32:1346-9.
51.
Weidner W., Schoen U., Pust R., Rothauge C.Thorotrastkatzinom nach Vesikulographie bei chronischer Prostatitis . Z Urol Nephrol1981;74:95-100.
52.
Nielsen M., Albrechsten R., Johnsen N., Vilsfeldt J.Carcinoma of the parotid gland following sialography with thorotrast . Acta Otolaryngol1979;88:462-7.
53.
Goren A., Harley N., Eisenbud L., Levin S., Cohen N.Clinical and radiobiologic features of thorotrast-induced carcinoma of the maxillary sinus: a case report. Oral Surg1980; 49:237-44.
54.
Hasson J., Hartman K., Milikow E., Mittleman J.Thorotrast-induced extraskeletal osteosarcoma of the cervical region . Cancer1975;36:1827-33.
55.
Harrist T., Schiller A., Trelstad R., Mankin H., Mays C.Thorotrast-associated sarcoma of the bone: a case report and review of the literature. Cancer1979;44:2049-58.
56.
Heger N., Bayindir S.Thorotrast: primary liver sarcoma 22 years after administration. Minn Med1970:33:1137-9.
57.
Wargotz E., Sidawy M., Janotta F.Thorotrast-associated gliosarcoma: including comments on thorotrast use and review of sequelae particular, reference to lesions of the central nervous system. Cancer1988;62:58-66.
58.
Thiel H., Schott D., Schejbal V., Horster H-G.Panmyelopathie und metastasierendes Hemangioendotheliom der Leber nach Thorotrastapplikation . Med Klin1979 ;74: 1451-5,
59.
Meyer M., Powell H., Wagner M., Niwayama G.Thorotrast induced adhesive arachnoiditis associated with meniagioma and schwannoma . Hum Pathol1978;9:366-70.
60.
Sussman S., TerBrugge K., Solt L., Deck J.Thorotrast-induced meningioma. J. Neurosurg1980;52:834-7.
61.
Kylc R., Oler A., Lasser E.Meningioma induced by thorium dioxide. N Engl J Med1963;268:80-2.
62.
Saragoca T. , Tavares M., Barros F., da Silva Horta J.Some clinical and laboratory findings in patients injected with thorium dioxide. Am J Gastroenterol1983;57:301-10.
63.
Silverman P. , Ram P., Korobkin M.CT appearance of abdominal thorotrast deposition and thorotrast-induced angiosarcoma of the liver. J Comput Tomogr1983;7:655-8.
64.
Khan A.Thorotrast-associated liver cancer. Am J Gastroenterol1987;80-699-703.
65.
Barth V., Hamm B.Maligne Lebertumoren auf der Basis einer Thorotrastose: Vergleich von Ultrachall, Computertomgraphie und Kernspintomographie. Roentgenpraxis1987;40:220-3.
66.
Findley A., Chidress M.Computed tomography of thorotrastosis. J Comput Tomogr1987; 11: 188-9.
67.
Kiyosawa K. , Akahane Y., Miyazaki Y., et al. Resection of Thorotrast-induced cholangiocarcinoma . Am J Gastroenterol1983;78:429-33.
68.
Imai H., Kiyosawa K., Nakamura M., Gibo Y., Sodeyama T., Furuta S.A case of cholangiocartinoma detected after follow-up for seven years for thorotrast deposition. Gastroenterologia Japonica1989;23:570-5.
69.
Murgo A.Thrombotic microngiopathy in the cancer patient, including those induced by chemotherapeutic agents. Semin Hematol1987 ;24:161-77.
70.
Ludmerer K. , Kissane J.Microangiopathic anemia and disseminated intravascular coagulation in an elderly woman. Am J Med1383;74.1052-60.
71.
Kressell B. , Ryan K., Duong A., et al. Microangiopathic hemolytic anemia, thrombocytopenia and renal failure in patients treated for adenocarcinoma . Cancer1981;48:1738-45.
72.
Baker W.Clinical aspects of disseminated intravascular coagulation: a clinician's point of view. Semin Thromb Hemostas1989;15:1-57.
73.
Bick R.Disorders of hemostasis and thrombosis. New York : Thieme, 1985:157-204.
74.
Bick R.Disseminated intravascular coagulation and related syndromes: a clinical review . Semin Thromb Hemost1988; 14:299.
75.
Bick R.Alteration of hemostasis associated with malignancy. Semin Thromb Hemost1978;x:51-26.
Punukollu R. , Gopalswamy N.The hepatorenal syndrome. Med Clin North Am1990;74:933-43.
78.
Cohn J.Hepatocirculatory failure: diverse pathogeneses deserve diverse therapies . Hepatology1990;11:510-1.
79.
Ring-Larsen H., Palazzo U.Renal failure in fulminant hepatic failure and terminal cirrhosis: a comparison between incidence, types, and prognosis . Gut1981;22:385-91.
80.
Davidson E. , Dunn M.Pathogenesis of the hepatorenal syndrome. Ann Rev Med1987;38:361-72.
81.
Locker G., Doroshow J., Zwelling L., Chabner B.The clinical features of hepatic angiosarcoma: a report of four cases and a review of the English literature. Medicine (Baltimore) 1979;58:48-64.
82.
Spirtas R., Beebe G., Baxter P., et al. Angiosarcoma as a model for comparative carcinogenesis. Lancet1983;x:456.
83.
Vasile N., Larde D., Zafrini E., Berard H., Mathieu D.Case report: hepatic angiosarcoma. J Comput Assist Tomogr1983;7:899-901.
84.
Guzelian P.Hepatic injury due to environmental agents . Clin Lab Med1984;4:483-8.
85.
Lefkowitch J.The epidemiology and morphology of primary malignant liver tumors. Surg Clin North Am1981;61: 169-81.
86.
Alrenga D.Primary angiosarcoma of the liver. Int Surg1975;60:198.
87.
Antar M., Kassamali H., Spencer R.Sequential loss of splenic and then hepatic function in a patient with thorotrast loading. Clin Nucl Med1989 ;14:634-5.
88.
Stewart G.The infective hazards of splenectomy. Aust NZ J Surg1979,49:492.
89.
Dickerman J.Bacterial infection and the asplenic host: a review. J Trauma1976;16:662-8.
90.
Hague A., Min K., From P., et al. Postsplenectomy pneumococcemia in adults. Arch Pathol Lab Med1980;104:258-60.
91.
Muller-Berghaus G.Pathophysiology of generalized intravascular coagulation. Semin Thromb Hemost1977;3:209-46.
92.
Minna J., Robboy S., Colman R.Disseminated intravascular coagulation in man. Springfield : Charles C Thomas, 1974.
93.
Muller-Berghaus G., Roka L., Lasch H.Induction of glomerular microclot formation by fibrin monomer infusion. Thromb Diath Hemorrh1973;29:375-83.
94.
Roboy S., Colman R., Minna J.Pathology of disseminated intravascular coagulation (DIC): analysis of 26 cases. Hum Pathol1972;3:327-43.
95.
Skjorten F.Hyalin microthrombi in autopsy material: a quantitative study with discussion of the relationship to small vessel thrombosis . Acta Pathol Microbiol Scand1969;76:361-75.
96.
Gentilini P. , Laffi G.Renal functional impairment and sodium retention in liver cirrhosis. Digestion1989;43:1-32.
97.
Henriksen J. , Ring-Larsen H.Ascites formation in liver cirrhosis: the how and the why. Dig Dis1990;8:152-62.
98.
Papadakis M. , Arieff A.Unpredictability of clinical evaluation of renal function in cirrhosis. Am J Med1987 ;82:945-52.
99.
Epstein M., Oster J., de Velasco R.Hepatorenal syndrome following hemihepatectomy. Clin Nephrol1976;5:128-33.
100.
Davenport A., Aulton K., Payne R., Will E.Hyperlactatemia and increasing metabolic acidosis in hepatorenal failure treated by hemofiltration . Renal Fail1990;12:99-101.
101.
Mant M., King E.Chronic disseminated intravascular coagulation due to occult carcinoma . Am J Med Sci1979;274: 69-74.
102.
Haynes B.Enlargement of lymph nodes and spleen. In: Wilson J, Braunwald E, Isselbacher K, et al., eds. Harrison's textbook of internal medicine, 12th ed. New York: McGraw-Hill Inc, 1991.
103.
Castro-Malaspina H., Rabellino E., Yen A., Nachman R., Moore M.Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts. Blood1981;57:781-7.
104.
Bick R., Baker W., Patel R.Diagnostic efficacy of the D-dimer assay in DIC and related disorders (D-dimer assay). Blood1986;68:329.
105.
Van Kaick G , Kaul H.Follow-up study. In: Van Kaick G, Kaul H, eds. Radiation protection. The German thorotrast study. Luxembourg : Commission of the European Communities, 1984.
106.
Levy D., Rindsberg S., Friedman A., et al. Thorotrast-induced hepatosplenic neoplasia. Am J Radiol1986;146: 997-1004.
107.
Fitzgerald E., Griffiths T.Case reports: computed tomography of vinyl-chloride-induced angiosarcoma of liver. Brit J Radiol1987;60:593-5.
108.
Freeny P.Angiography of hepatic neoplasms. Semin Roent1983;18:114-22.
